SureTrader
Interactive Brokers Advertisement
SureTrader
Home > Boards > US Listed > Biotechs >

CytomX Therapeutics, Inc. (CTMX)

CTMX RSS Feed
Add CTMX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 6/4/2017 10:18:27 AM - Followers: 3 - Board type: Free - Posts Today: 0

CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition, it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., ImmunoGen, Inc., and The University of Texas M. D. Anderson Cancer Center to develop selected Probody therapeutics. The company was founded in 2008 and is headquartered in South San Francisco, California.
CTMX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTMX News: Statement of Changes in Beneficial Ownership (4) 06/22/2017 02:01:42 PM
CTMX News: Statement of Changes in Beneficial Ownership (4) 06/22/2017 02:00:23 PM
CTMX News: Statement of Changes in Beneficial Ownership (4) 06/22/2017 01:59:28 PM
CTMX News: Statement of Changes in Beneficial Ownership (4) 06/22/2017 01:59:01 PM
CTMX News: Statement of Changes in Beneficial Ownership (4) 06/22/2017 01:58:33 PM